Racivir

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Racivir
Racivir.svg
Clinical data
Routes of
administration
Investigational
ATC code
  • none
Identifiers
CAS Number
PubChem CID
ChemSpider
NIAID ChemDB
Chemical and physical data
Formula C8H10FN3O3S
Molar mass 247.25 g/mol
3D model (JSmol)

Racivir is an experimental nucleoside reverse transcriptase inhibitor (NRTI), developed by Pharmasset for the treatment of HIV.[1] It is the enantiomer of emtricitabine, a widely used NRTI, meaning that the two compounds are mirror images of each other.

Emtricitabine, the enantiomer of racivir and a widely used NRTI

References[edit]

  1. ^ "Racivir". AIDSmeds.com. March 24, 2006. Archived from the original on 2014-01-02. Retrieved March 21, 2008.